Short answer
Prime Medicine, Inc. (PRME) filed an 8-K current report with the SEC on May 7, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q1 2026 results and business highlights announced for quarter ended March 31, 2026.
Prime Medicine, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results and business highlights announced for quarter ended March 31, 2026
- Full financial details and operating updates contained in Exhibit 99.1
- Results announcement provides investors an update on Prime Medicine’s financial condition and business progress
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Prime Medicine, Inc. 8-K filings
Get the next PRME 8-K as it lands
Follow PRME for push alerts, or ask the research agent what this filing means.